Company: LHI
Filing Date: 2025-01-27
Form Type: DRS/A
Source: 0001213900-25-006939
Chunk: 167

Company: Living Homeopathy International Ltd.
Filing Date: 2025-01-27
Form: DRS/A
Chunk 167
---
 Kenrick B Toussaintqualifies as an audit committee financial expert within the meaning of the SEC rules or possesses financial sophistication within the meaning of the Nasdaq Listing Rules. The audit committee will oversee our accounting and financial reporting processes and the audits of the financial statements of our company. The audit committee will be responsible for, among other things:

| ● | appointing                                                                                  
 the independent auditors and pre-approving all auditing and non-auditing services permitted 
 to be performed by the independent auditors;                                                |

| ● | reviewing                                                                                   
 with the independent auditors any audit problems or difficulties and management’s response; |

| ● | discussing                                                                            
 the annual audited financial statements with management and the independent auditors; |

| ● | reviewing                                                                                     
 the adequacy and effectiveness of our accounting and internal control policies and procedures 
 and any steps taken to monitor and control major financial risk exposures;                    |

| ● | reviewing                                              
 and approving all proposed related party transactions; |

| ● | meeting                                                                       
 separately and periodically with management and the independent auditors; and |

| ● | monitoring                                                                                
 compliance with our code of business conduct and ethics, including reviewing the adequacy 
 and effectiveness of our procedures to ensure proper compliance.                          |

Compensation Committee.Our compensation committee will consist of Chun Fai Fong, Kenrick B Toussaint and Zhou Bin. Chun Fai Fong will be the chairman of our compensation committee. The compensation committee will assist the board in reviewing and approving the compensation structure, including all forms of compensation, relating to our directors and executive officers. Our chief executive officer may not be present at any committee meeting during which his compensation is deliberated. The compensation committee will be responsible for, among other things:

| ● | reviewing                                                                                     
 and approving to the board with respect to the total compensation package for our most senior 
 executive officers;                                                                           |

| ● | approving                                                                                   
 reviewing and recommending to the board with respect to the compensation of our directors;  
 and overseeing the total compensation package for our executives other than the most senior 
 executive officers;                                                                         |

| ● | selecting                                                                                 
 compensation consultants, legal counsel or other advisors after taking into consideration 
 all factors relevant to that person’s independence from management; and                   |

| ● | programs                                                                             
 or similar arrangements, annual bonuses, employee pension and welfare benefit plans. |

<div align='center'>97</div>

Nominating and Corporate Governance Committee.Our nominating and corporate governance committee will consist of Zhou Bin, Kenrick B Toussaint